Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-20 4:08 pm Unchanged | 2022-11-14 | 13D | SPERO THERAPEUTICS INC SPRO | GSK PLC | 9,190,606 17.750% | 0 (Unchanged) | Filing History |
| 2022-11-14 5:02 pm Purchase | 2022-11-07 | 13D | SPERO THERAPEUTICS INC SPRO | GSK PLC | 9,190,606 19.990% | 7,450,000 (+428.01%) | Filing History |
| 2022-11-04 4:08 pm Purchase | 2021-06-16 | 13D | 23ANDME HLDG CO ME | GSK PLC | 1,983,024 13.200% | 1,983,024 (New Position) | Filing History |
| 2022-09-20 4:12 pm Sale | 2022-09-16 | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK PLC | 0 0.000% | -9,644,807 (Position Closed) | Filing History |
| 2022-08-03 08:33 am Unchanged | 2022-08-03 | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK PLC | 9,644,807 12.700% | 0 (Unchanged) | Filing History |
| 2022-07-27 4:24 pm Purchase | 2022-07-17 | 13D | HALEON PLC ADR HLN | GSK PLC | 1,195,320,110 12.940% | 1,195,320,110 (New Position) | Filing History |
| 2022-05-13 4:14 pm Unchanged | 2022-04-28 | 13D | NKARTA INC NKTX | GSK PLC | 3,161,432 6.800% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:31 pm Purchase | 2021-12-31 | 13G | GSK PLC SPONSORED ADS REPRES T GSK | Dodge & Cox | 115,706,643 5.900% | 115,706,643 (New Position) | Filing History |
| 2022-02-10 4:55 pm Purchase | 2021-12-31 | 13G | GENOCEA BIOSCIENCES INC GNCA | GSK PLC | 5,861,389 9.900% | 644,000 (+12.34%) | Filing History |
| 2022-02-10 4:51 pm Purchase | 2021-12-31 | 13G | LYELL IMMUNOPHARMA INC LYEL | GSK PLC | 1,512,659 12.600% | 1,512,659 (New Position) | Filing History |
| 2022-02-10 4:50 pm Sale | 2021-12-31 | 13G | F-STAR THERAPEUTICS INC FSTX | GSK PLC | 802,627 3.900% | -1,295 (-0.16%) | Filing History |
| 2022-02-10 4:48 pm Unchanged | 2021-11-08 | 13D | THERAVANCE BIOPHARMA INC TBPH | GSK PLC | 9,644,807 13.100% | 0 (Unchanged) | Filing History |
| 2022-02-10 4:46 pm Purchase | 2021-12-31 | 13G | VIR BIOTECHNOLOGY INC VIR | GSK PLC | 8,550,954 6.500% | 1,924,927 (+29.05%) | Filing History |
| 2022-02-07 4:40 pm Purchase | 2021-12-31 | 13G | GSK PLC SPONSORED ADR GSK | BlackRock Inc. BLK | 385,777,418 7.800% | 15,737,013 (+4.25%) | Filing |
| 2021-09-27 06:01 am Unchanged | 2021-08-16 | 13G | FULCRUM THERAPEUTICS INC FULC | GSK PLC | 1,785,714 4.500% | 0 (Unchanged) | Filing History |
| 2021-09-16 5:27 pm Unchanged | 2021-08-05 | 13D | SPERO THERAPEUTICS INC SPRO | GSK PLC | 1,740,606 5.400% | 0 (Unchanged) | Filing History |
| 2021-09-16 5:22 pm Sale | 2021-08-05 | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | GSK PLC | 1,529,561 6.000% | -86,734 (-5.37%) | Filing History |
| 2021-07-12 4:52 pm Purchase | 2021-07-02 | 13G | CVRX INC CVRX | GSK PLC | 1,007,583 5.000% | 1,007,583 (New Position) | Filing History |
| 2021-05-25 4:24 pm Sale | 2021-05-20 | 13D | INNOVIVA INC INVA | GSK PLC | 0 0.000% | -32,005,260 (Position Closed) | Filing History |
| 2021-04-16 4:17 pm Sale | 2021-04-09 | 13D | BICYCLE THERAPEUTICS PLC SPONS BCYC | GSK PLC | 1,616,295 7.000% | -278,536 (-14.70%) | Filing History |